ALSO IN THIS MONTH'S ISSUE

  • Hospitals Drive More Costs, Get Less Scrutiny
    Hospitals Drive More Costs, Get Less Scrutiny

    Stepping back from the political hyperbole driving the prescription-drug debate is that American taxpayers, patients, and employers spend far more on hospitals than pharmaceuticals. Yet hospitals receive very little scrutiny of their escalating costs.

  • Athira’s Whole-Patient Drug Development
    Athira’s Whole-Patient Drug Development

    One company is atypical in the industry for its use of patient and caregiver input to guide its drug-development journey. That shows in the program for its lead drug entering later-stage trials in treating Alzheimer’s disease.

  • Companies To Watch: Leading Biosciences
    Companies To Watch: Leading Biosciences

    Leading Biosciences is applying the science of digestive proteases to treating or preventing multiple diseases and conditions, starting with delayed return of post-surgical bowel function (ileus) and adhesion with its lead product candidate, coded LB1148.

  • Comparative Biosimilar Clinical Trials: More Questions Than Answers?
    Comparative Biosimilar Clinical Trials: More Questions Than Answers?

    As one expert said, though there are many reasons to praise clinical trials for their contributions to drug development, they may not always be the best method to answer some of the most important biosimilar questions we have today.

  • My Advice To Aspiring Biopharma Entrepreneurs
    My Advice To Aspiring Biopharma Entrepreneurs

    When it comes to achieving success, a few commonalities have crystallized for me during my 30+ years in the pharma industry. Here I share five key tenets that I have found critical to success over the arc of my career.

More from this month's issue

BEYOND THE PRINTED PAGE

More beyond the printed page articles

 EVENTS

Understanding and Implementing the EU Regulation for Initiating and Conducting Clinical Trials September 19 - 19, 2019
1pm-2:30pm EDT, Online Training
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!
Root Cause Analysis & CAPA Identification: A Step-by-Step Guide for Manufacturers September 24 - 24, 2019
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Stability Programs – Key Factors in Meeting FDA/ICH Expectations September 26 - 26, 2019
1pm-2:30pm EDT, Online Training
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!
SCDM 2019 Annual Conference September 29, 2019 - October 2, 2019
Baltimore, MD
Sterility Failure Investigations – A Step-by-Step Process for Success September 30 - 30, 2019
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
More events....

SEPTEMBER 2019 DIGITAL EDITION

2019 CMO & CRO AWARDS EDITIONS

   

@LIFESCILEADER1